Literature DB >> 19264750

Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study.

Serge Boveda1, Eloi Marijon, Sophie Jacob, Pascal Defaye, Jobst B Winter, Alan Bulava, Daniel Gras, Jean Paul Albenque, Nicolas Combes, Dominique Pavin, Nicolas Delarche, Alexander Teubl, Marie Lambiez, Philippe Chevalier.   

Abstract

AIMS: The aim of this study was to investigate the 12-month incidence, predictive factors, and prognosis of sustained ventricular tachycardia (VT) in chronic heart failure patients implanted with biventricular pacemakers without a back-up defibrillator (CRT-P), assessed by continuous intracardiac ventricular electrograms. METHODS AND
RESULTS: The Mona Lisa study, a prospective, multicentre, cohort study, designed to determine the incidence of sustained VT and its prognostic impact in CRT-P recipients within the year after implant enrolled 198 patients with moderate or severe chronic heart failure, despite optimal pharmacological therapy. An independent committee reviewed the data from all arrhythmic episodes as well as causes of death according to predefined criteria. During a mean follow-up of 9.8 +/- 3.1 months after implantation, 8 patients experienced at least one episode of sustained VT [4.3%; 95% confidence interval (CI), 1.1-7.5] and 21 deaths occurred, giving a 12-month mortality rate of 11.7% (95% CI, 6.4-16.9). The presence of sustained VT was associated with a high risk of sudden cardiac death (SCD) and the lowest 12-month overall survival (P < 0.0001).
CONCLUSION: The incidence of sustained VT remains relatively low in the first year after CRT-P implantation, but when present appears closely associated with short-term adverse outcomes, especially SCD. This emphasizes the possible value of remote monitoring to detect high-risk patients for urgent upgrading.

Entities:  

Mesh:

Year:  2009        PMID: 19264750     DOI: 10.1093/eurheartj/ehp071

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

Review 1.  [Non-device-based telemonitoring : Toy or tool?]

Authors:  Martin Stockburger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-08-22

2.  Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction.

Authors:  Pieter Martens; Dieter Nuyens; Maximo Rivero-Ayerza; Hugo Van Herendael; Jan Vercammen; Wendy Ceyssens; Evert Luwel; Matthias Dupont; Wilfried Mullens
Journal:  Clin Res Cardiol       Date:  2019-02-20       Impact factor: 5.460

3.  Comparison of partners-heart failure algorithm vs care alert in remote heart failure management.

Authors:  Leonardo Calo'; Annamaria Martino; Claudia Tota; Alessandro Fagagnini; Renzo Iulianella; Marco Rebecchi; Luigi Sciarra; Giuseppe Giunta; Maria Grazia Romano; Roberto Colaceci; Antonio Ciccaglioni; Fabrizio Ammirati; Ermenegildo de Ruvo
Journal:  World J Cardiol       Date:  2015-12-26

4.  Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.

Authors:  Stefan Sack; Christian Michael Wende; Herbert Nägele; Amos Katz; Wolfgang Rudolf Bauer; Craig Scott Barr; Klaus Malinowski; Harald Schwacke; Francisco Leyva; Jochen Proff; Sergey Berdyshev; Vincent Paul
Journal:  Eur J Heart Fail       Date:  2011-09       Impact factor: 15.534

5.  Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

Authors:  Eloi Marijon; Christophe Leclercq; Kumar Narayanan; Serge Boveda; Didier Klug; Jonathan Lacaze-Gadonneix; Pascal Defaye; Sophie Jacob; Olivier Piot; Jean-Claude Deharo; Marie-Cecile Perier; Genevieve Mulak; Jean-Sylvain Hermida; Paul Milliez; Daniel Gras; Olivier Cesari; Françoise Hidden-Lucet; Frederic Anselme; Philippe Chevalier; Philippe Maury; Nicolas Sadoul; Pierre Bordachar; Serge Cazeau; Michel Chauvin; Jean-Philippe Empana; Xavier Jouven; Jean-Claude Daubert; Jean-Yves Le Heuzey
Journal:  Eur Heart J       Date:  2015-09-01       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.